Q
Quratis develops vaccines and cell therapies specifically targeting tuberculosis, utilizing advanced immunological techniques to enhance the body's immune response. The company addresses the global health challenge of tuberculosis by providing effective therapeutic options that aim to reduce infection rates and improve patient outcomes.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Quratis develops vaccines and cell therapies specifically targeting tuberculosis, utilizing advanced immunological techniques to enhance the body's immune response. The company addresses the global health challenge of tuberculosis by providing effective therapeutic options that aim to reduce infection rates and improve patient outcomes.